IndraLab

Statements

USP18 inhibits Ptpn2. 2 / 2

| 2

reach

"Furthermore, treatment with the ROS inhibitor Mitotempo efficiently inhibited the USP18 deficiency-mediated opening of mPTP (Fig. 5B)."

37978268

➶

reach

"Furthermore, while usp18-KO enhanced mPTP opening in DENV-infected cells, overexpression of USP18 inhibited mPTP opening (Supplementary Fig. 8)."

37978268

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP18 inhibits Ptpn2. 2 / 2

INDRA sources:

Databases

Reading